Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Refractory immune-related adverse events (irAEs) associated with immune checkpoint inhibitor therapy: a multiorgan management review.
Journal: Expert opinion on drug safety
Published: April 17, 2026
Chronic sequelae of immune-related adverse events.
Journal: Expert opinion on drug safety
Published: February 23, 2026
Chronic sequelae of immune-related adverse events.
Journal: Expert opinion on drug safety
Published: February 23, 2026
Rare irAEs associated with immune checkpoint inhibitor therapy.
Journal: Expert opinion on drug safety
Published: February 10, 2026
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis Outcomes.
Journal: Gastro hep advances
Published: April 15, 2025
Diagnostic delay in type I autoimmune pancreatitis: clinical, imaging, endoscopic and histologic predictors of timely diagnosis.
Journal: Translational gastroenterology and hepatology
Published: April 15, 2025
Validation of the immune-mediated colitis endoscopic score using a retrospective cohort of patients with immune-mediated colitis.
Journal: iGIE : innovation, investigation and insights
Published: April 01, 2025
Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment Options.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 01, 2025
Predictive Value of FDG Uptake on PET for Future Immune Checkpoint Inhibitor-Mediated Colitis: A Case Series.
Journal: Journal of clinical medicine
Published: December 07, 2024
The Effect of Immune Checkpoint Inhibitor Therapy on Pre-Existing Gastroparesis and New Onset of Symptoms of Delayed Gastric Emptying.
Journal: Cancers
Published: June 17, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026